Literature DB >> 20850911

New octahydroquinazoline derivatives: synthesis and hypotensive activity.

O I el-Sabbagh1, Mohamed A Shabaan, Hanan H Kadry, Ehab Saad Al-Din.   

Abstract

Several novel 1-(4-chlorophenyl)-7,7-dimethyl-1,2,3,4,5,6,7,8-octahydro-5-oxo-3-(substitutedphenyl)quinazoline derivatives (2-21) structurally similar to prazosin, were prepared using Mannich reaction of 3-(4-chlorophenylamino)-5,5-dimethyl-2-cyclohexenone (1) with different aromatic amines in the presence of formaline. The structures of the quinazoline derivatives were established using elemental and spectral analyses. Compounds 18, 20 and 21 were found to possess a high hypotensive effect through their expected α(1)-blocking activity like the clinically used drug prazosin but with advantageous of being did not cause reflex tachycardia and having prolonged duration of action when tested in adrenaline-induced hypertension in anaesthetized rats.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850911     DOI: 10.1016/j.ejmech.2010.08.064

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

Review 1.  Advances in the design and synthesis of prazosin derivatives over the last ten years.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Expert Opin Ther Targets       Date:  2011-12-13       Impact factor: 6.902

Review 2.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

Review 3.  Therapeutic potential of hydrazones as anti-inflammatory agents.

Authors:  Anu Kajal; Suman Bala; Neha Sharma; Sunil Kamboj; Vipin Saini
Journal:  Int J Med Chem       Date:  2014-03-04

4.  Synthesis and antihypertensive screening of new derivatives of quinazolines linked with isoxazole.

Authors:  Mujeeb Ur Rahman; Ankita Rathore; Anees A Siddiqui; Gazala Parveen; M Shahar Yar
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.